🇺🇸 FDA

Intelligence · Clinical Pipeline

R&D Pipeline Programs

ClinicalTrials.gov programs linked to pharma sponsors — phase, modality, and trial IDs for BD and competitive intelligence.

Programs indexed
20,548
Companies
1,769
Drugs tracked
4,797

Quick answer

NovaPharmaNews tracks 20,548 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text — searchable for business development and competitive intelligence.

2,153 results for “Ou” Clear

  1. inactivated EV71 vaccine (KMB-17 cells)

    Chinese University of Hong Kong

    Hand, Foot and Mouth Disease (HFMD)

    approved mab completed

    1 trial

  2. intravenous NAC

    CUMBERLAND PHARMACEUTICALS INC

    Nephropathy

    approved small molecule active

    1 trial

  3. intravenous sufentanil

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Analgesia, Patient-Controlled

    approved small molecule completed

    1 trial

  4. intravenous tranexamic acid (TXA) infusion

    The First People's Hospital of Lianyungang

    Spontaneous Intracranial Hemorrhage

    approved small molecule active

    1 trial

  5. lactate group:lactate acide clearance directed group; ScvO2 group:ScvO2 directed group;control group

    Chinese University of Hong Kong

    Shock, Septic

    approved other completed

    1 trial

  6. low-dose tenecteplase intravenous thrombolysis

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Acute Ischemic Stroke Patients

    approved small molecule active

    1 trial

  7. mouse nerve growth factor

    The First People's Hospital of Lianyungang

    Cerebral Small Vessel Diseases

    approved small molecule active

    1 trial

  8. profound neuromuscular blockade

    The First People's Hospital of Lianyungang

    Profound Muscle Relaxation

    approved small molecule active

    1 trial

  9. rhGM-CSF group

    Biotech Pharmaceutical Co.,

    Mycoses

    approved small molecule completed

    1 trial

  10. rhGM-CSF group

    The First People's Hospital of Lianyungang

    Mycoses

    approved small molecule completed

    1 trial

  11. rhTPO

    Sunshine Guojian Pharmaceutical (Shanghai) Co.,

    Previously Treated Primary Immune Thrombocytopenia

    approved small molecule completed

    1 trial

  12. risperidone

    Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co.,

    Neuroleptic-Induced Tardive Dyskinesia

    approved small molecule completed

    1 trial

  13. rituximab combined with corticosteroids

    The First People's Hospital of Lianyungang

    Primary Membranous Nephropathy

    approved small molecule active

    1 trial

  14. tasimelteon 20 mg capsule

    Vanda Pharmaceuticals Netherlands B.V.

    Non-24-Hour-Sleep-Wake Disorder

    approved small molecule completed

    1 trial

  15. 30% Nitrous oxide

    BRIGHT MINDS BIOSCIENCES INC.

    Opioid-Related Disorders

    small molecule completed

    2 trials

  16. A continuous intravenous infusion of 0.5-0.6 mg/kg/h Rocuronium Bromide Intravenous Solution (50 Mg/5 mL) to keep the target neuromuscular blockade (PTC = 1-2).

    The First People's Hospital of Lianyungang

    Neuromuscular Blockade

    small molecule completed

    1 trial

  17. A single dose of liposomal bupivacaine is administered at the conclusion of surgery without adjunctive analgesics, followed by a supplemental dose 72 hours postoperatively.

    The First People's Hospital of Lianyungang

    Anal Fistula

    small molecule active

    1 trial

  18. ASC09/ritonavir group

    The First People's Hospital of Lianyungang

    2019-nCoV

    small molecule terminated

    1 trial

  19. Aescin in Horse Chestnut

    Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co.,

    Anorectal Disorder

    small molecule active

    1 trial

  20. Albumin-Bound Paclitaxel

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Gastric Carcinoma

    small molecule active

    1 trial

  21. Amorphous calcium carbonate

    Universal Integrated

    Calcium

    other active

    1 trial

  22. Anti-BCMA and CD19 CART cells will be injected intravenously on a one-time basis.

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Autoimmune Diseases

    small molecule active

    1 trial

  23. Artificial Intelligence Enabled Transvaginal Ultrasound Imaging algorithm

    The First People's Hospital of Lianyungang

    Ovarian Cancer

    other active

    1 trial

  24. Boost to the tumour bed

    United Therapeutics Europe Ltd

    Early Breast Cancer

    other active

    1 trial

Frequently asked questions

What is the NovaPharmaNews pipeline directory?

It is a searchable index of 20,548 clinical development programs grouped by sponsor company, with phase (Phase 1–3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.

Where does pipeline data come from?

Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.

How do I find pipeline programs by company or phase?

Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.

Data attribution and licensing: Data sources